{
    "organizations": [],
    "uuid": "75766b52c3f9de134ae775ac1ad03372106f9d5a",
    "author": "Stephen Wilmot",
    "url": "https://www.wsj.com/articles/durex-maker-reckitt-avoids-20-billion-headache-1521724748",
    "ord_in_thread": 0,
    "title": "Durex-Maker Reckitt Avoids $20 Billion Headache",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Having turned down Advil, Reckitt Benckiser needs to find another treatment for the headache of weak growth.\nThe U.K.-based consumer group, which makes Clearasil acne cream, Durex condoms and Lysol sanitizers, announced late Wednesday that it had ended its pursuit of Pfizer’s consumer-health unit. The U.S. health care giant put its nonprescription business, which is expected to fetch up to $20 billion, on the block last October. Reckitt’s retreat seemingly leaves the path clear for GlaxoSmithKline, the global leader in branded... To Read the Full Story Subscribe Sign In",
    "published": "2018-03-22T16:19:00.000+02:00",
    "crawled": "2018-03-22T15:33:56.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "turned",
        "advil",
        "reckitt",
        "benckiser",
        "need",
        "find",
        "another",
        "treatment",
        "headache",
        "weak",
        "growth",
        "consumer",
        "group",
        "make",
        "clearasil",
        "acne",
        "cream",
        "durex",
        "condom",
        "lysol",
        "sanitizers",
        "announced",
        "late",
        "wednesday",
        "ended",
        "pursuit",
        "pfizer",
        "unit",
        "health",
        "care",
        "giant",
        "put",
        "nonprescription",
        "business",
        "expected",
        "fetch",
        "billion",
        "block",
        "last",
        "october",
        "reckitt",
        "retreat",
        "seemingly",
        "leaf",
        "path",
        "clear",
        "glaxosmithkline",
        "global",
        "leader",
        "branded",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}